Pulmonary function is associated with frailty, hospitalization and mortality in older people: 5-year follow-up: Pulmonary function as a predictor of frailty

dc.contributor.affiliationUniversidad de Las Americas - Chile
dc.contributor.affiliationInstituto de Salud Carlos III
dc.contributor.affiliationUniversidade Estadual de Londrina
dc.contributor.affiliationUniversity Norte Parana
dc.contributor.affiliationComplejo Hospitalario de Toledo
dc.contributor.affiliationHospital Universitario de Getafe
dc.contributor.authorSepulveda-Loyola, Walter
dc.contributor.authorCarnicero, Jose A.
dc.contributor.authorAlvarez-Bustos, Alejandro
dc.contributor.authorProbst, Vanessa Suziane
dc.contributor.authorGarcia-Garcia, Francisco J.
dc.contributor.authorRodriguez-Manas, Leocadio
dc.date.accessioned2023-06-12T16:01:42Z
dc.date.available2023-06-12T16:01:42Z
dc.date.issued2023-05
dc.description.abstractBackground: The relationship between pulmonary impairment and frailty has rarely been studied in commu-nity-dwelling older adults. Objective: This study aimed to analyze the association between pulmonary function and frailty (prevalent and incident), identifying the best cut-off points to detect frailty and its association with hospitalization and mortality. Methods: A longitudinal observational cohort study with 1188 community-dwelling older adults was taken from the Toledo Study for Healthy Aging. The forced expiratory volume in the first second (FEV1) and the forced vital capacity (FVC) were measured with spirometry. Frailty was evaluated using the Frailty Phenotype and Frailty Trait Scale 5. Associations between pulmonary function and frailty, hospitalization and mortality in a 5-year follow-up and the best cut-off points for FEV1 and FVC were analyzed. Results: FEV1 and FVC were associated with frailty prevalence (OR from 0.25 to 0.60), incidence (OR from 0.26 to 0.53), and hospitalization and mortality (HR from 0.35 to 0.85). The cut-off points of pulmonary function identified in this study: FEV1 (<1.805 L for male and <1.165 L for female) and FVC (<2.385 L for male and <1.585 L for female) were associated with incident frailty (OR: 1.71-4.06), hospitalization (HR: 1.03-1.57) and mortality (HR: 2.64-5.17) in individuals with and without respiratory diseases (P < 0.05 for all). Conclusion: Pulmonary function was inversely associated with the risk of frailty, hospitalization and mortality in community-dwelling older adults. The cut-off points for FEV1 and FVC to detect frailty were highly associated with hospitalization and mortality in the 5-year follow-up, regardless of the existence of pulmo-nary diseases.(c) 2023 Elsevier Inc. All rights reserved.
dc.description.sponsorshipThis work was supported by grants from the Spanish Ministry of Economy, Industry and Competitiveness, financed by the European Regional Development Funds and the Centro de Investigación Biomédica en Red en Fragilidad y Envejecimiento Saludable ( CB16/10/00464 ), and the Fundación Francisco Soria Melguizo (Section 2/2020 ). The research leading to these results has also received support from the Innovative Medicines Initiative Joint Undertaking under grant agreement n◦ 115621 , resources of which are composed of financial contribution from the European Union’ Seventh Framework Programme ( FP7/2007–2013 ) and EFPIA companies’ in-kind contribution. This funding sources had no role in the design of the study, its execution, analyses and data interpretation or decision to submit results. WSL was supported by the Brazilian National Council for Scientific and Technological Development (CNPq).
dc.format.mimetypeapplication/pdf
dc.identifier.citationHeart and Lung, 59, 88-94. https://doi.org/10.1016/j.hrtlng.2023.01.020
dc.identifier.doihttps://doi.org/10.1016/j.hrtlng.2023.01.020
dc.identifier.issn0147-9563
dc.identifier.orcidhttps://orcid.org/0000-0002-6551-1333
dc.identifier.orcidhttps://orcid.org/0000-0002-3431-7204
dc.identifier.orcidhttps://orcid.org/0000-0003-3690-6069
dc.identifier.orcidhttps://orcid.org/0000-0001-6173-1104
dc.identifier.orcidhttps://orcid.org/0000-0002-5537-9201
dc.identifier.pmid36796248
dc.identifier.researcheridGYU-8290-2022
dc.identifier.researcheridR-9258-2017
dc.identifier.researcheridV-1546-2019
dc.identifier.researcheridAFL-1127-2022
dc.identifier.researcheridH-2173-2018
dc.identifier.rorhttps://ror.org/04j0sev46
dc.identifier.rorhttps://ror.org/00ca2c886
dc.identifier.rorhttps://ror.org/01585b035
dc.identifier.rorhttps://ror.org/00vvm7f23
dc.identifier.rorhttps://ror.org/0166e9x11
dc.identifier.scopusauthorid58289745600
dc.identifier.scopusauthorid57205090636
dc.identifier.scopusauthorid57201487862
dc.identifier.scopusauthorid7003939332
dc.identifier.scopusauthorid57199662920
dc.identifier.scopusauthorid7004685679
dc.identifier.urihttps://repositorio.udla.cl/handle/udla/1162
dc.language.isoeng
dc.publisherElsevier BV
dc.relation.fundingFundación Francisco Soria Melguizo
dc.relation.fundingSeventh Framework Programme, FP7
dc.relation.fundingCentro de Investigación Biomédica en Red Fragilidad y Envejecimiento Saludable, CIBERFES, (CB16/10/00464)
dc.relation.fundingCentro de Investigación Biomédica en Red Fragilidad y Envejecimiento Saludable, CIBERFES
dc.relation.fundingEuropean Federation of Pharmaceutical Industries and Associations, EFPIA
dc.relation.fundingConselho Nacional de Desenvolvimento Científico e Tecnológico, CNPq
dc.relation.fundingEuropean Regional Development Fund, ERDF
dc.relation.fundingMinisterio de Asuntos Económicos y Transformación Digital, Gobierno de España, MINECO
dc.relation.fundingInnovative Medicines Initiative, IMI, (115621)
dc.relation.fundingInnovative Medicines Initiative, IMI
dc.relation.isindexedbyWeb of Science
dc.rights.urihttps://www.elsevier.com/tdm/userlicense/1.0/
dc.sourceHEART & LUNG
dc.source.urihttps://www.sciencedirect.com/science/article/pii/S0147956323000201
dc.subjectFrailty syndrome
dc.subjectRespiratory function test
dc.subjectAging
dc.subjectPublic health
dc.subjectCut-point
dc.subjectOlder adults
dc.subject.lcshPulmonary function tests
dc.subject.lcshAging
dc.subject.lcshOlder people
dc.subject.oecd13 Ciencias Médicas y de la Salud
dc.subject.oecd23.2 Medicina Clínica
dc.titlePulmonary function is associated with frailty, hospitalization and mortality in older people: 5-year follow-up: Pulmonary function as a predictor of frailty
dc.title.alternativePulmonary function is associated with frailty, hospitalization and mortality in older people: 5-year follow-up
dc.title.alternativePulmonary function is associated with frailty, hospitalization and mortality in older people: 5-year follow-up.
dc.typejournal article
dc.type.coarhttp://purl.org/coar/resource_type/c_6501
dc.type.driverinfo:eu-repo/semantics/article
oaire.citation.endPage94
oaire.citation.startPage88
oaire.citation.titleHEART & LUNG
oaire.citation.volume59
udla.curacion.controljmvg
udla.odsODS 3: Salud y bienestar
udla.oecd.area3 Ciencias Médicas y de la Salud
udla.oecd.subarea3.2 Medicina Clínica

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Pulmonary function is associated with frailty hospitalization and mortality in older people 5-year follow-up.png
Size:
262.65 KB
Format:
Portable Network Graphics
Description:
Sepulveda et al 2023 Pulmonary function is associated with frailty, hospitalization and mortality in older people: 5-year follow-up

License bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:

Collections